“global-blood-therapeutics” Archives

in
Entry Author Date Location
Biotech Roundup: BIO on Racism, AbbVie Antibodies, IPO Surge & More 06/12/20 National
Imara Reveals IPO Plan as Sickle Cell Drug Advances in the Clinic 02/18/20 Boston
Global Blood’s Sickle Cell Drug Wins FDA Approval Ahead of Schedule 11/25/19 San Francisco
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone 09/06/19 National
GlycoMimetics Sickle Cell Drug Flops as Others Creep Forward 08/05/19 New York
15 For ’19: Key Clinical Data to Watch For Next Year (Part 2) 12/18/18 National
ASH 2018: Three Up, Two Down as Big Blood Disease Meeting Rolls On 12/03/18 National
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More 11/26/18 National
Pliant Picks Up $62M to Test Lung, Liver Fibrosis Drug in the Clinic 07/16/18 San Francisco
GBT Eyes Fast Nod for Sickle Cell Drug but Won’t Use Patient-Reported Data 06/27/18 San Francisco
For Sickle Cell, a Complex Disease, New Drugs Could Bring Complex Costs 06/15/18 San Francisco
Biotech Roundup: Obamacare Lite, DePinho Out, Dunsire In & More 03/10/17 National
ASH Roundup: CAR-T Shuffle, Hemophilia Updates, Checkpoint Progress & More 12/06/16 National
Third Rock Gets $616M to Grow New Crop of Biotech Startups 10/31/16 Boston
Bio Roundup: Drug Pricing, Cystic Fibrosis Showdown, Myovant & More 10/28/16 National
Cydan, NEA’s Orphan Drug Accelerator, Targets Sickle Cell With Startup Imara 04/14/16 Boston
At Hematological Meeting, More Than Just Biotech Data Runs Blood Red 12/08/15 National
Voyager Charts an IPO Course Amid Choppy Biotech Waters 10/11/15 Boston
100 Years But Only One Drug: Sickle Cell Patients Wait For Help 08/18/15 National
West Coast Biotech Roundup: Global Blood, Invitae, GeneWEAVE, Adynxx 08/13/15 San Francisco
Global Blood Therapeutics Garners $120,000,000 New Financing 08/12/15 San Francisco
Global Blood Thera Nabs $120M IPO, Doubles Share Price On First Day 08/11/15 San Francisco
West Coast Bio Roundup: Cowboys, UCSD v. USC, Global Blood & More 07/10/15 San Diego
Tackling Sickle Cell, Global Blood Therapeutics Joins IPO Queue 07/08/15 San Francisco
Pop That Bubble: 5 Reasons Biotech Needs A Different Metaphor 04/14/15 National
West Coast Biotech Roundup: Tobira, Novartis, NantCell, & More 01/15/15 San Francisco
West Coast Biotech Roundup: Hep C, 23andMe, Kite, Cash, Isis & More 01/08/15 San Francisco
One Week Into The New Year, Five Biotechs Reel in $220M Venture Cash 01/08/15 National
Global Blood Therapeutics Garners $48,000,000 Series B Funding Round 01/06/15 San Francisco
“Innovation at Biotech’s Epicenter,” Dec. 17: Check Out the Agenda 12/10/14 San Francisco
Page 1 of 2 next page »